|Slideshows|December 18, 2019

7 Clinical Applications of Mindfulness

Medicine and psychology have integrated the basic principles of mindfulness into many diverse treatment modalities. Seven are listed here.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

New Research Explores the Genetic Roots of Hair-Pulling and Skin-Picking, Connection to OCD

ByLeah Kuntz

August 31st 2026

Podcast: The Case for Integrative Psychiatry

ByErin Crown, MHS, PA-C, Psych-CAQ,Laura Melaro, DNP, APRN, FNP-BC, PMHNP-BC

August 25th 2026

Advocating for Integrative Care: On the Mind of Laura Melaro, DNP, APRN, FNP-BC, PMHNP-BC

ByErin Crown, MHS, PA-C, Psych-CAQ,Laura Melaro, DNP, APRN, FNP-BC, PMHNP-BC

August 25th 2026

Patent Application Published: MDMA-N-Acylethanolamines for the Treatment of PTSD, Anxiety, and Eating Disorders

ByLeah Kuntz

August 24th 2026

Collaborative Psychiatric-Dermatologic Care Improves Outcomes for Complex Patients

ByJames A. Bourgeois, OD, MD,Xiaofeng Yan, MD, PhD

August 21st 2026

Latest CME

In-Person Event

Jersey City Psychiatry

October 2-3, 2026

Register now!

Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

Video

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

Video

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia

Gus Alva, MD, DFAPA; Erin Crown, MHS, PA-C

7 Clinical Applications of Mindfulness

Related Content

New Research Explores the Genetic Roots of Hair-Pulling and Skin-Picking, Connection to OCD

Podcast: The Case for Integrative Psychiatry

Advocating for Integrative Care: On the Mind of Laura Melaro, DNP, APRN, FNP-BC, PMHNP-BC

Patent Application Published: MDMA-N-Acylethanolamines for the Treatment of PTSD, Anxiety, and Eating Disorders

Collaborative Psychiatric-Dermatologic Care Improves Outcomes for Complex Patients

Latest CME

Jersey City Psychiatry

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia

Trending on Psychiatric Times

When Treatment-Resistant Depression Means Mismatched: Rethinking Difficult-to-Treat Depression

Repurposing Dopamine Agonist Pramipexole for Disabling Anhedonia

Brain Trust: Anita H. Clayton, MD, on Diagnosing and Treating Sexual Dysfunction

The Year So Far in GLP-1s: What Psychiatric Clinicians Need to Know

GLP-1 Receptor Agonists Linked to Lower Mortality, Cardiovascular Events in Serious Mental Illness